Background: LncRNA GAS8-AS1 inhibits thyroid carcinoma, but its function in other
malignancies is unknown. The present study aimed to investigate the involvement of GAS8 …

Long noncoding RNAs (lncRNAs) are aberrantly expressed in various cancers. Although
lncRNA GAS5 (growth arrest-specific transcript 5) has been characterized as a tumor …

Accumulating evidence has shown that long noncoding RNA GAS5 is a well-known tumor
suppressor in the pathogenesis of a variety of human cancers. However, the detailed role of …

Long noncoding RNAs (lncRNAs) are known to exert their effects to tumor progression. In
this study, the role of the lncRNA GAS5 (growth arrest specific 5) was confirmed in reducing …

Hepatocellular carcinoma (HCC) is the third leading cause of cancer‑related mortality
worldwide. Recent studies have demonstrated that long non‑coding RNAs (lncRNAs) are …

Objective It is already known that long non-coding RNA growth arrest-specific 5 (GAS5) is
downregulated in human colorectal cancer (CRC) cells inhibiting cell proliferation. We …

Abstract Introduction: Long non-coding RNAs (lncRNAs) have been investigated as a new
class of regulators of cellular processes, such as cell growth, apoptosis, and carcinogenesis …

Long non-coding RNAs (lncRNAs) are recognized as critical regulators of self-renewal in
human cancer stem-like cells (CSCs), which are a subpopulation of cancer cells primarily …

Osteosarcoma is a common malignant bone tumor. Cisplatin (DDP) achieves a high
response rate in osteosarcoma. Here we aim to study the dysregulation of long non-coding …

Objective This study aims to investigate the effect of long non-coding RNA (lncRNA) Gas5
on proliferation, migration, invasion and apoptosis of colorectal cancer (CRC) HT-29 cell …